Search - tctmd.com

Displaying 141 - 160 of 7110

Sort: Relevancy | Date

Presentation TCT 2016

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, Deepak L. Bhatt

November 01, 2016

Presentation TCT 2016

If You Do Image, Which Is The Tool For BRS - IVUS, HD-IVUS, Or OCT?

Presenter: Jonathan M. Hill, Christoph K. Naber, Carlo Di Mario

November 01, 2016

Presentation TCT 2016

Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder

Presenter: Krzysztof Bartus, Saibal Kar

November 01, 2016

Presentation TCT 2016

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Routine!

Presenter: Jonathan M. Hill, Christoph K. Naber, Ricardo A. Costa

November 01, 2016

Presentation TCT 2016

TCT 400: The Importance of Implantation Technique in Ensuring Optimal Outcomes After Bioresorbable Scaffold Implantation: Implications From a Real-World Cohort

Presenter: Ronald Caputo, Maurizio Menichelli

November 01, 2016

Presentation TCT 2016

Flash Debate: Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Selective!

Presenter: Jonathan M. Hill, Christoph K. Naber, Joanna J. Wykrzykowska

November 01, 2016

Presentation TCT 2016

General Principles of LAA Closure

Presenter: Krzysztof Bartus, Apostolos Tzikas

November 01, 2016

Presentation TCT 2016

The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx

November 01, 2016

Presentation TCT 2016

Can QCA Be Trusted? Insights From OCT and More

Presenter: Jonathan M. Hill, Christoph K. Naber, Yoshinobu Onuma

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: PLATINUM DIVERSITY

Presenter: Philip M. Urban, Stephen G. Worthley, Bonnie H. Weiner

November 01, 2016

Presentation TCT 2016

TCT 399: Impact of Post-Dilatation on Angiographic and Clinical Outcomes of Patients Undergoing Bioresorbable Scaffold Implantation in Clinical Practice

Presenter: Ronald Caputo, Maurizio Menichelli

November 01, 2016

Presentation TCT 2016

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, C. Michael Gibson

November 01, 2016

Presentation TCT 2016

BRS Sizing Considerations: Eyeball, Catheter or Inflated Balloon Guidance, QCA or Intracoronary Imaging (With Case Examples)?

Presenter: Jonathan M. Hill, Christoph K. Naber, Alexandre Abizaid

November 01, 2016

Presentation TCT 2016

Accurate: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Helge Möllmann

November 01, 2016

Presentation TCT 2016

Lesion Preparation: Techniques and Devices, A Lesion-Specific Approach (With Case Examples)

Presenter: Jonathan M. Hill, Christoph K. Naber, Corrado Tamburino

November 01, 2016

Presentation TCT 2016

Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CAD and ACS

Presenter: Jonathan M. Hill, Christoph K. Naber, Manel Sabate

November 01, 2016

Presentation TCT 2016

Direct Flow: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Azeem Latib

November 01, 2016

Presentation TCT 2016

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Presenter: Philip M. Urban, Stephen G. Worthley, Stephen G. Ellis

November 01, 2016

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

Advertisement

The RE-DUAL PCI Trial: Dabigatran in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

If You Do Image, Which Is The Tool For BRS - IVUS, HD-IVUS, Or OCT?

Special Tips and Tricks for LAA Closure Using the Watchman LAA Occluder

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Routine!

TCT 400: The Importance of Implantation Technique in Ensuring Optimal Outcomes After Bioresorbable Scaffold Implantation: Implications From a Real-World Cohort

Flash Debate: Selective or Routine Intracoronary Imaging for BVS Implantation? Pro-Selective!

General Principles of LAA Closure

The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status

Can QCA Be Trusted? Insights From OCT and More

Highlights (and my Interpretations) From: PLATINUM DIVERSITY

TCT 399: Impact of Post-Dilatation on Angiographic and Clinical Outcomes of Patients Undergoing Bioresorbable Scaffold Implantation in Clinical Practice

The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status

BRS Sizing Considerations: Eyeball, Catheter or Inflated Balloon Guidance, QCA or Intracoronary Imaging (With Case Examples)?

Accurate: Design Features, Special Attributes, and Clinical Trial Program

Lesion Preparation: Techniques and Devices, A Lesion-Specific Approach (With Case Examples)

Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CAD and ACS

Direct Flow: Design Features, Special Attributes, and Clinical Trial Program

Highlights (and My Interpretations) From: Absorb BVS - ABSORB II and ABSORB China (2-3 Year Results)

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content